Yüklüyor......
Effect of Glucagon-like peptide-1 agonist (liriglutide) on weight and glycemic control among adults with type 2 diabetes mellitus attending primary care center at security forces hospital in Riyadh, Saudi Arabia
INTRODUCTION: Liraglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist), also known as incretin mimetics. This is the new approach for management of weight among diabetic patients along with glycemic controls. The study aims to explore the efficacy of Liraglutide on weight (...
Kaydedildi:
| Yayımlandı: | J Family Med Prim Care |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer - Medknow
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7586614/ https://ncbi.nlm.nih.gov/pubmed/33110789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jfmpc.jfmpc_361_20 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|